Advisor Resource Council’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Advisor Resource Council’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,953	Closed	-$221K	–	623
2025 Q1	$221K	Buy	+1,953	New	+$243K	0.02%	532

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Advisor Resource Council's ITCI Position: Q2 2025 in Review

Advisor Resource Council sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 1,953 shares — an estimated $221K sold.

Advisor Resource Council first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $221K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Advisor Resource Council reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Advisor Resource Council sold 1,953 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $221K.
Advisor Resource Council first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Advisor Resource Council's Intra-Cellular Therapies Inc. position peaked at $221K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Advisor Resource Council's 13F filing for Q2 2025, filed 11 Aug 2025.